Skip to main content
. 2017 Dec 8;12(12):e0189079. doi: 10.1371/journal.pone.0189079

Fig 4. Percentage of HIV-positive women eligible for AZT prophylaxis who are cumulatively lost at each stage of the PMTCT cascade.

Fig 4